Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 60

1.

HSC extrinsic sex-related and intrinsic autoimmune disease-related human B-cell variation is recapitulated in humanized mice.

Borsotti C, Danzl NM, Nauman G, Hölzl MA, French C, Chavez E, Khosravi-Maharlooei M, Glauzy S, Delmotte FR, Meffre E, Savage DG, Campbell SR, Goland R, Greenberg E, Bi J, Satwani P, Yang S, Bathon J, Winchester R, Sykes M.

Blood Adv. 2017 Oct 13;1(23):2007-2018. doi: 10.1182/bloodadvances.2017006932. eCollection 2017 Oct 24.

2.

Concomitant angiosarcoma and lymphoproliferative disorder in solid organ transplant recipients.

Baer LN, Savage DG, Hibshoosh HH, Kalinsky K.

Clin Sarcoma Res. 2014 Oct 31;4(1):15. doi: 10.1186/2045-3329-4-15. eCollection 2014.

3.

Measurement of ratios of νμ charged-current cross sections on C, Fe, and Pb to CH at neutrino energies 2-20 GeV.

Tice BG, Datta M, Mousseau J, Aliaga L, Altinok O, Barrios Sazo MG, Betancourt M, Bodek A, Bravar A, Brooks WK, Budd H, Bustamante MJ, Butkevich A, Martinez Caicedo DA, Castromonte CM, Christy ME, Chvojka J, da Motta H, Devan J, Dytman SA, Díaz GA, Eberly B, Felix J, Fields L, Fiorentini GA, Gago AM, Gallagher H, Gran R, Harris DA, Higuera A, Hurtado K, Jerkins M, Kafka T, Kordosky M, Kulagin SA, Le T, Maggi G, Maher E, Manly S, Mann WA, Marshall CM, Martin Mari C, McFarland KS, McGivern CL, McGowan AM, Miller J, Mislivec A, Morfín JG, Muhlbeier T, Naples D, Nelson JK, Norrick A, Osta J, Palomino JL, Paolone V, Park J, Patrick CE, Perdue GN, Rakotondravohitra L, Ransome RD, Ray H, Ren L, Rodrigues PA, Savage DG, Schellman H, Schmitz DW, Simon C, Snider FD, Solano Salinas CJ, Tagg N, Valencia E, Velásquez JP, Walton T, Wolcott J, Zavala G, Zhang D, Ziemer BP; MINERvA Collaboration.

Phys Rev Lett. 2014 Jun 13;112(23):231801. Epub 2014 Jun 9.

PMID:
24972195
4.
5.

A model for personalized in vivo analysis of human immune responsiveness.

Kalscheuer H, Danzl N, Onoe T, Faust T, Winchester R, Goland R, Greenberg E, Spitzer TR, Savage DG, Tahara H, Choi G, Yang YG, Sykes M.

Sci Transl Med. 2012 Mar 14;4(125):125ra30. doi: 10.1126/scitranslmed.3003481.

6.
7.

A critical analysis of prognostic factors in North American patients with human T-cell lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma: a multicenter clinicopathologic experience and new prognostic score.

Phillips AA, Shapira I, Willim RD, Sanmugarajah J, Solomon WB, Horwitz SM, Savage DG, Bhagat G, Soff G, Zain JM, Alobeid B, Seshan VE, O'Connor OA.

Cancer. 2010 Jul 15;116(14):3438-46. doi: 10.1002/cncr.25147.

8.

Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.

Montanari F, O'Connor OA, Savage DG, Zain JM, Venkatraman S, McCormick EK, Crook MT, Tsao L, Sevilla DW, Bhagat G, Alobeid B.

Hum Pathol. 2010 Aug;41(8):1150-8. doi: 10.1016/j.humpath.2009.11.016. Epub 2010 Apr 8.

PMID:
20381113
9.

A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patients.

Phillips AA, Willim RD, Savage DG, Horwitz SM, Isola L, Zain JM, O'Connor OA.

Leuk Lymphoma. 2009 Jun;50(6):1039-42. doi: 10.1080/10428190902887571. No abstract available.

PMID:
19373596
10.

Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement.

Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG, Bhagat G.

Leuk Lymphoma. 2009 May;50(5):831-3. doi: 10.1080/10428190902795527. No abstract available.

PMID:
19330656
11.

Application of pulsed-field gel electrophoresis to identify the source of bacterial contamination of peripheral blood progenitor cell products.

Reich-Slotky R, Wu F, Della-Latta P, Savage DG, Schwartz J.

Transfusion. 2008 Nov;48(11):2409-13. doi: 10.1111/j.1537-2995.2008.01851.x. Epub 2008 Jul 22.

PMID:
18657076
12.

The spectrum of B-cell non-Hodgkin lymphomas with dual IgH-BCL2 and BCL6 translocations.

Keller CE, Nandula S, Fisher J, Subramaniyam S, Vakiani E, Savage DG, Murty VV, Alobeid B, Bhagat G.

Am J Clin Pathol. 2008 Aug;130(2):193-201. doi: 10.1309/ELPKF130Q0MCMWU8.

PMID:
18628087
13.

Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.

Hirano M, Martí R, Casali C, Tadesse S, Uldrick T, Fine B, Escolar DM, Valentino ML, Nishino I, Hesdorffer C, Schwartz J, Hawks RG, Martone DL, Cairo MS, DiMauro S, Stanzani M, Garvin JH Jr, Savage DG.

Neurology. 2006 Oct 24;67(8):1458-60. Epub 2006 Sep 13.

14.

Phase I/II study of tandem cycles of high-dose chemotherapy followed by autologous hematopoietic stem cell support in women with advanced ovarian cancer.

Tiersten A, Selleck M, Smith DH, Wertheim I, Kaufman E, Hershman D, Vahdat LT, Savage DG, MacArthur RB, Hesdorffer C.

Int J Gynecol Cancer. 2006 Jan-Feb;16(1):57-64.

PMID:
16445611
15.

Primary Burkitt lymphoma of the uterine corpus.

Keller C, Savage DG, Rusta-Villa M, Bhagat G, Alobeid B.

Leuk Lymphoma. 2006 Jan;47(1):141-5.

PMID:
16321839
16.

T-Cell lymphoblastic lymphoma presenting as bilateral multinodular breast masses: a case report and review of the literature.

Vakiani E, Savage DG, Pile-Spellman E, El-Tamer M, Singh IR, Murty VS, Alobeid B, Bhagat G.

Am J Hematol. 2005 Nov;80(3):216-22.

17.

Unusual leukemia presentations. Case 3. Type I IgGlambda cryoglobulinemia associated with chronic lymphocytic leukemia.

Mantha S, Jacobs MI, Savage DG.

J Clin Oncol. 2005 Aug 20;23(24):5841-3. No abstract available.

PMID:
16110039
18.

Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphoma.

Papadopoulos KP, Noguera-Irizarry W, Wiebe L, Hesdorffer CS, Garvin J, Nichols GL, Vahdat LH, Lo KM, Skerrett D, Bernstein D, Sharpe E, Savage DG.

Bone Marrow Transplant. 2005 Sep;36(6):491-7.

PMID:
16044139
19.

Reduced dose imatinib mesylate therapy for chronic myeloid leukemia.

Zipin D, Savage DG.

Leuk Lymphoma. 2004 Nov;45(11):2363-4. No abstract available.

PMID:
15512833
20.

Hemophagocytic, non-secretory multiple myeloma.

Savage DG, Zipin D, Bhagat G, Alobeid B.

Leuk Lymphoma. 2004 May;45(5):1061-4.

PMID:
15291368
21.

Chronic idiopathic myelofibrosis: independent prognostic importance of bone marrow microvascular density evaluated by CD105 (endoglin) immunostaining.

Ponzoni M, Savage DG, Ferreri AJ, Pruneri G, Viale G, Servida P, Bertolini F, Orazi A.

Mod Pathol. 2004 Dec;17(12):1513-20.

22.

Outcomes of unrelated cord blood transplantation in pediatric recipients.

Styczynski J, Cheung YK, Garvin J, Savage DG, Billote GB, Harrison L, Skerrett D, Wolownik K, Wischhover C, Hawks R, Bradley MB, Del Toro G, George D, Yamashiro D, van de Ven C, Cairo MS.

Bone Marrow Transplant. 2004 Jul;34(2):129-36.

PMID:
15107815
23.

Combined fludarabine and rituximab for low grade lymphoma and chronic lymphocytic leukemia.

Savage DG, Cohen NS, Hesdorffer CS, Heitjan D, Oster MW, Garrett TJ, Bar M, del Prete S, March R, Lonberg M, Talbot S, Mears JG, Flamm M, Taub RN, Nichols G.

Leuk Lymphoma. 2003 Mar;44(3):477-81.

PMID:
12688318
24.

Leptomeningeal relapse of multiple myeloma following allogeneic stem cell transplantation.

Savage DG, Mears JG, Balmaceda C, Rescigno J, Shendrik I, Mansukhani M, Orazi A.

Leuk Res. 2002 Jul;26(7):689-92. Review.

PMID:
12008088
25.

Imatinib mesylate--a new oral targeted therapy.

Savage DG, Antman KH.

N Engl J Med. 2002 Feb 28;346(9):683-93. Review. No abstract available.

PMID:
11870247
26.

Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria.

Araten DJ, Swirsky D, Karadimitris A, Notaro R, Nafa K, Bessler M, Thaler HT, Castro-Malaspina H, Childs BH, Boulad F, Weiss M, Anagnostopoulos N, Kutlar A, Savage DG, Maziarz RT, Jhanwar S, Luzzatto L.

Br J Haematol. 2001 Nov;115(2):360-8. Review.

PMID:
11703336
27.

Membranous glomerulopathy associated with graft-versus-host disease following allogeneic stem cell transplantation. Report of 2 cases and review of the literature.

Lin J, Markowitz GS, Nicolaides M, Hesdorffer CS, Appel GB, D'Agati VD, Savage DG.

Am J Nephrol. 2001 Sep-Oct;21(5):351-6. Review.

PMID:
11684793
28.

Rituximab for bone lymphoma.

Savage DG, Staron R.

Ann Intern Med. 2001 Jun 19;134(12):1156-7. No abstract available.

PMID:
11412072
29.

Gemcitabine for relapsed or resistant lymphoma.

Savage DG, Rule SA, Tighe M, Garrett TJ, Oster MW, Lee RT, Ruiz J, Heitjan D, Keohan ML, Flamm M, Johnson SA.

Ann Oncol. 2000 May;11(5):595-7.

PMID:
10907954
30.

Etiology and diagnostic evaluation of macrocytosis.

Savage DG, Ogundipe A, Allen RH, Stabler SP, Lindenbaum J.

Am J Med Sci. 2000 Jun;319(6):343-52.

PMID:
10875288
31.

A phase I study of high-dose BCNU, etoposide and escalating-dose thiotepa (BTE) with hematopoietic progenitor cell support in adults with recurrent and high-risk brain tumors.

Papadopoulos KP, Balmaceda C, Fetell M, Kaufman E, Vahdat LT, Bruce J, Sisti M, Isaacson S, De LaPaz R, Savage DG, Troxel A, Antman KH, Hesdorffer CS.

J Neurooncol. 1999 Sep;44(2):155-62.

PMID:
10619499
32.

Pancytopenia in Zimbabwe.

Savage DG, Allen RH, Gangaidzo IT, Levy LM, Gwanzura C, Moyo A, Mudenge B, Kiire C, Mukiibi J, Stabler SP, Lindenbaum J.

Am J Med Sci. 1999 Jan;317(1):22-32.

PMID:
9892268
33.

High-dose thiotepa and etoposide-based regimens with autologous hematopoietic support for high-risk or recurrent CNS tumors in children and adults.

Papadopoulos KP, Garvin JH, Fetell M, Vahdat LT, Garrett TJ, Savage DG, Balmaceda C, Bruce J, Sisti M, Isaacson S, De LaPaz R, Hawks R, Bagiella E, Antman KH, Hesdorffer CS.

Bone Marrow Transplant. 1998 Oct;22(7):661-7.

34.
35.

Allografting for chronic myeloid leukemia.

Savage DG, Goldman JM.

Curr Opin Hematol. 1997 Nov;4(6):369-76. Review.

PMID:
9358991
36.

Paranasal sinusitis following allogeneic bone marrow transplant.

Savage DG, Taylor P, Blackwell J, Chen F, Szydlo RM, Rule SA, Spencer A, Apperley JF, Goldman JM.

Bone Marrow Transplant. 1997 Jan;19(1):55-9. Review.

37.
38.

Intermediate-dose busulphan before autografting for advanced-phase chronic myeloid leukaemia.

Rule SA, Savage DG, O'Brien SG, Orchard K, McDonald C, Davidson J, Matthey F, Reilly JT, Bardhan G, Miller E, Cranfield T, Apperley JF, Goldman JM.

Br J Haematol. 1996 Sep;94(4):694-8.

PMID:
8826894
39.

97Tc produced by the (3He,pn gamma ) reaction.

Aslan H, Crowe B, Dague T, Savage DG, Zeghib S, Rickey FA, Simms PC.

Phys Rev C Nucl Phys. 1996 Aug;54(2):576-592. No abstract available.

PMID:
9971381
40.

Assessment of brain changes with registered MR before and after bone marrow transplantation for chronic myeloid leukemia.

Jäger HR, Williams EJ, Savage DG, Rule SA, Hajnal JV, Sikora K, Goldman JM, Bydder GM.

AJNR Am J Neuroradiol. 1996 Aug;17(7):1275-82.

41.

Abundant folate in Zimbabwean beer.

Savage DG, Gangaidzo IT, Bennie A.

Alcohol Clin Exp Res. 1995 Dec;19(6):1596. No abstract available.

PMID:
8749834
42.

Neurological complications of acquired cobalamin deficiency: clinical aspects.

Savage DG, Lindenbaum J.

Baillieres Clin Haematol. 1995 Sep;8(3):657-78. Review.

PMID:
8534966
43.

Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. 1988.

Lindenbaum J, Healton EB, Savage DG, Brust JC, Garrett TJ, Podell ER, Marcell PD, Stabler SP, Allen RH.

Nutrition. 1995 Mar-Apr;11(2):181; discussion 180, 182. No abstract available.

PMID:
7647490
44.

Approaches to the treatment of chronic myeloid leukemia.

Savage DG, Goldman JM.

Int J Hematol. 1994 Jul;60(1):1-21. Review.

PMID:
7919235
45.
46.

Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency.

Allen RH, Stabler SP, Savage DG, Lindenbaum J.

FASEB J. 1993 Nov;7(14):1344-53. Review.

PMID:
7901104
47.
48.

Elevation of serum cystathionine levels in patients with cobalamin and folate deficiency.

Stabler SP, Lindenbaum J, Savage DG, Allen RH.

Blood. 1993 Jun 15;81(12):3404-13.

PMID:
8507876
49.

New approaches to the diagnosis of cobalamin (Cbl, vitamin B12) deficiency in neuropsychiatric disorders.

Allen RH, Stabler SP, Savage DG, Lindenbaum J.

J Nutr Sci Vitaminol (Tokyo). 1992;Spec No:130-3. No abstract available.

PMID:
1297723
50.

Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiency.

Stabler SP, Allen RH, Barrett RE, Savage DG, Lindenbaum J.

Neurology. 1991 Oct;41(10):1627-32.

PMID:
1922806

Supplemental Content

Loading ...
Support Center